JANX
MODERATEJanux Therapeutics, Inc.
CIK: 0001817713
Last activity: Jan 2, 2026
Financial Metrics
As of Dec 31, 2024 (10-K)
Insider Roster (6 total, 6 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
|
Meyer Andrew Hollman
Chief Business Officer
|
0 | 3 | -$136K |
83,095 shares
$1.14M
|
|
Campbell David Alan
President and CEO
|
0 | 1 | -$111K |
284,982 shares
$3.91M
|
|
McIver Zachariah
Chief Medical Officer
|
0 | 1 | -$37K |
23,286 shares
$320K
|
|
DiRaimondo Thomas
Chief Scientific Officer
|
0 | 1 | -$34K |
124,425 shares
$1.71M
|
|
Winter Charles M.
Chief Technical Officer
|
0 | 1 | -$33K |
77,721 shares
$1.07M
|
|
Dobek Maria
Vice President, Accounting
|
0 | 1 | -$20K |
15,373 shares
$211K
|
Recent Transactions
8,072 shares @ $13.73
$111K
Jan 2, 2026
2,714 shares @ $13.73
$37K
Jan 2, 2026
2,505 shares @ $13.73
$34K
Jan 2, 2026
2,401 shares @ $13.73
$33K
Jan 2, 2026
1,879 shares @ $13.73
$26K
Jan 2, 2026
1,462 shares @ $13.73
$20K
Jan 2, 2026
2,700 shares @ $32.85
$89K
Dec 1, 2025
633 shares @ $33.52
$21K
Dec 1, 2025
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.